News
12-14-2007, 03:55 AM
The long-term findings of a large, multicenter study show thatbreast cancer survival is significantly improved and side effectsare significantly less severe with Taxotere (also called docetaxel)than with Adriamycin (also called doxorubicin).
More... (http://www.healthcentral.com/breast-cancer/news-197313-66.html)
More... (http://www.healthcentral.com/breast-cancer/news-197313-66.html)